<DOC>
	<DOCNO>NCT00055952</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness exatecan mesylate treat patient relapsed refractory Ewing 's sarcoma peripheral primitive neuroectodermal tumor desmoplastic small round cell tumor .</brief_summary>
	<brief_title>Exatecan Mesylate Treating Patients With Ewing 's Sarcoma , Primitive Neuroectodermal Tumor , Desmoplastic Small Round Cell Tumor</brief_title>
	<detailed_description>OBJECTIVES : - Determine objective response rate patient Ewing 's sarcoma , primitive neuroectodermal tumor , desmoplastic small round cell tumor treat exatecan mesylate . - Determine time tumor progression patient treat drug . - Determine median survival 6- 12-month survival patient treated drug . - Determine pain response patient treated drug . - Determine qualitative quantitative toxic effect drug patient . - Determine pharmacokinetics drug patient . OUTLINE : This open-label , non-randomized , multicenter study . Patients stratify accord disease ( relapsed refractory localize metastatic Ewing 's sarcoma primitive neuroectodermal tumor vs desmoplastic small round cell tumor ) . Patients receive exatecan mesylate IV 30 minute day 1-5 . Treatment repeat every 21 day absence disease progression unacceptable toxicity maximum 12 course , 6 course beyond maximal response ( whichever longer ) . Patients follow every 3 month 1 year withdrawal study . PROJECTED ACCRUAL : A total 13-27 patient accrue stratum I within 12 month . A total 9-17 patient accrue stratum II within 15 month .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Desmoplastic Small Round Cell Tumor</mesh_term>
	<mesh_term>Exatecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow histologically confirm diagnosis : Relapsed refractory Ewing 's sarcoma primitive neuroectodermal tumor Desmoplastic small round cell tumor Measurable disease The following consider measurable disease : Ascites Pleural effusion Lytic bone lesions No symptomatic brain metastasis PATIENT CHARACTERISTICS : Age Any age Performance status ECOG 02 ( 10 year age ) Lansky 60100 % ( 10 year age ) Life expectancy At least 12 week Hematopoietic Absolute neutrophil count least 750/mm^3 Platelet count least 75,000/mm^3 Hemoglobin least 8.5 g/dL Hepatic Bilirubin great 2.0 mg/dL AST ALT great 2.5 time upper limit normal ( ULN ) ( 5 time ULN liver metastasis present ) Albumin least 2.8 g/dL Renal Creatinine less 1.5 time ULN Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No active serious infection No malignancy within past 5 year except nonmelanoma skin cancer carcinoma situ cervix No overt psychosis mental disability would preclude informed consent No lifethreatening illness within past 6 month PRIOR CONCURRENT THERAPY : Biologic therapy At least 3 month since prior autologous bone marrow stem cell transplantation No concurrent biologic therapy Chemotherapy Recovered prior systemic chemotherapy Prior topoisomerase I inhibitor therapy allow No concurrent chemotherapy Endocrine therapy Not specify Radiotherapy More 4 week since prior cranial , spinal , whole pelvis radiotherapy More 4 week since prior radiotherapy 25 % bone marrow reserve No concurrent radiotherapy Surgery At least 4 week since prior major surgery recover No concurrent surgery Other More 28 day since prior investigational drug ( include analgesic antiemetic ) No 2 prior treatment regimen disease No investigational drug 28 day study therapy No concurrent anticancer therapy No concurrent grapefruit grapefruit juice</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>childhood desmoplastic small round cell tumor</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>localize Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
</DOC>